Jacob Adashek, DO @jacobadashek @USouthFlorida @MoffittNews @Dr_R_Kurzrock @AlexeyGoloubev #SITC20 #carcinomas Immunotherapy trials lack a biomarker for inclusion: implications for drug d…

Jacob Adashek, DO of The University of South Florida and H. Lee Moffitt Cancer Center & Research Institute discusses the Poster Presentation Immunotherapy trials lack a biomarker for inclusion: implications for drug development.

Poster Presentation #179

Immunotherapy research lacks a biomarker for inclusion: drug discovery implications.

Co-Authored by Alexey Goloubev; Shumei Kato, MD; Razelle Kurzrock, MD.